- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Featured Content
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Unpacking Amgen v. Sanofi
Aug 31st 2023
Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision.
Latest Videos
Latest News
How TekniPlex is Expanding to Support Innovative Solutions in Materials Science
May 17th 2024
TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.
IMA Life North America Breaks Ground on New Facility in Tonawanda, NY
May 17th 2024
The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.
New Cell Factory Box Launched by ProPharma and PBL for Automated CGT Manufacturing
May 7th 2024
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.
SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy
April 27th 2024
SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal
April 24th 2024
In a new agreement, Cellares will utilize its Cell Shuttle fully automated cell therapy manufacturing platform to manufacture select CAR-T cell therapies under development by Bristol Myers Squibb.
Charles River to Provide pDNA Manufacturing Services in Two Deals
April 11th 2024
Charles River has entered into separate agreements with Axovia Therapeutics and Ship of Theseus to offer plasmid DNA manufacturing services for a gene therapy and a lead candidate program, respectively.
Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy
April 5th 2024
Under a collaboration agreement, Lonza will manufacture sabirnetug, Acumen Pharmaceuticals' mAb in clinical development for treating Alzheimer’s disease.
Genmab Expands ADC Pipeline with $1.8 Billion Acquisition of ProfoundBio
April 4th 2024
Genmab's acquisition of ProfoundBio will boost its clinical and preclinical pipeline of ADCs for targeted cancer treatment.
Dr. Reddy’s Partners with Sanofi Healthcare India to Distribute Vaccines
March 29th 2024
Dr. Reddy’s has gained exclusive rights to promote and distribute Sanofi’s vaccines in India.
Roche Sells Large-Scale Biologics Manufacturing Site in US to Lonza for $1.2 Billion
March 26th 2024
The Vacaville, Calif., site acquisition gives Lonza one of the largest biologics manufacturing sites for mammalian cell-based therapies worldwide.